Analytical Procedure Validation and the Quality by Design Paradigm

REFERENCES

• Borman, P., Roberts, J., Jones, C., Hanna-Brown, M., Szucs, R., Bale, S. (2010). The development phase of an LC method using QbD principles. Separation Science 2:2–8.
   Google Scholar
• Dewé, W., Govaerts, B., Boulanger, B., Rozet, E., Chiap, P., Hubert, Ph. (2007). Using total error as decision criterion in analytical method transfer. Chemometrics and Intelligent Laboratory Systems 85:262–268.
   Google Scholar
• Ermer, J. (2011). A lifecycle concept for pharmaceutical analysis. European Pharmaceutical Review 16:16.
   Google Scholar
• Hubert, Ph., Nguyen-Huu, J.-J., Boulanger, B., Chapuzet, E., Chiap, P., Cohen, N., Compagnon, P.-A., Dewe, W., Feinberg, M., Lallier, M., Laurentie, M., Mercier, N., Muzard, G., Nivet, C., Valat, L. (2004). Harmonization of strategies for the validation of quantitative analytical procedures A SFSTP proposal --part I. Journal of Pharmaceutical and Biomedical Analyses 36:579–586.
   Google Scholar
• Hubert, Ph., Nguyen-Huu, J.-J., Boulanger, B., Chapuzet, E., Cohen, N., Compagnon, P.-A., Dewé, W., Feinberg, M., Laurentie, M., Mercier, N., Muzard, G., Valat, L., Rozet, E. (2007a). Harmonization of strategies for the validation of quantitative analytical procedures A SFSTP proposal --part II. Journal of Pharmaceutical and Biomedical Analyses 45:70–81.
   Web of Science ®Google Scholar
• Hubert, Ph., Nguyen-Huu, J.-J., Boulanger, B., Chapuzet, E., Cohen, N., Compagnon, P.-A., Dewé, W., Feinberg, M., Laurentie, M., Mercier, N., Muzard, G., Valat, L., Rozet, E. (2007b). Harmonization of strategies for the validation of quantitative analytical procedures A SFSTP proposal --part III. Journal of Pharmaceutical and Biomedical Analyses 45:82–96.
   Web of Science ®Google Scholar
• ICH Q2. (2005). International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva.
   Google Scholar
• ICH Q8. (2009). International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q8 (R2): Pharmaceutical Development, Geneva.
   Google Scholar
• ICH Q9. (2005). International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q9: Quality Risk Management, Geneva.
   Google Scholar
• ICH Q10. (2008). International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q10: Pharmaceutical Quality System, Geneva.
   Google Scholar
• Lebrun, P., Boulanger, B., Debrus, B., Lambert, Ph., Hubert, Ph. (2013). A Bayesian design space for analytical methods based on multivariate models and predictions. Journal of Biopharmaceutical Statistics 23:1330–1351.
   Google Scholar
• Lionberger, R. A., Lee, S. L., Lee, L., Raw, A., Yu, L. X. (2008). Quality by design: Concepts for ANDAs. AAPS Journal 10:268–276.
   Google Scholar
• Nethercote, P., Borman, P., Bennett, T., Martin, G., McGregor, P. (2010). QbD for better method validation and transfer. Pharmaceutical Manufacturing April:37.
   Google Scholar
• Peterson, J. J., Lief, K. (2010). The ICH Q8 definition of design space: A comparison of the overlapping means and the Bayesian predictive approaches. Statistics in Biopharmaceutical Research 2:249–259.
   Google Scholar
• Rozet, E., Govaerts, B., Lebrun, P., Michail, K., Ziemons, E., Wintersteiger, R., Rudaz, S., Boulanger, B., Hubert, Ph. (2011). Evaluating the reliability of analytical results using a probability criterion: A Bayesian perspective. Analytica Chimica Acta 705:193–206.
   Google Scholar
• Rozet, E., Hubert, C., Ceccato, A., Dewé, W., Ziemons, E., Moonen, F., Michail, K., Wintersteiger, R., Streel, B., Boulanger, B., Hubert, Ph. (2007). Using tolerance intervals in pre-study validation of analytical methods to predict in-study results-The fit-for-future-purpose concept. Journal of Chromatography A 1158:126–137.
   Google Scholar
• Rozet, E., Lebrun, P., Debrus, B., Boulanger, B., Hubert, Ph. (2013). Design spaces for analytical methods. TRAC, Trends in Analytical Chemistry 42:157–167.
   Web of Science ®Google Scholar
• Rozet, E., Ziemons, E., Marini, R. D., Boulanger, B., Hubert, Ph. (2012). Quality by design compliant analytical method validation. Analytical Chemistry 84:106.
   PubMed Web of Science ®Google Scholar
• Satterthwaite, F. E. (1941). Synthesis of variance. Psychometrika 6:309–316.
   Google Scholar
• Schweitzer, M., Pohl, M., Hanna-Brown, M., Nethercote, P., Borman, P., Hansen, G., Smith, K., Larew, J. (2010). Implications and opportunities of applying QbD principles to analytical measurements. Pharmaceutical Technology 34:52–59.
   Google Scholar
• Searle, S. R., Casella, G., McCulloch, C. E. (1992). Variance Components. New York, NY: Wiley.
   Google Scholar
• United States Food and Drug Administration (FDA). (2004). Guidance for industry PAT-A framework for innovative pharmaceutical manufacturing and quality assurance, FDA.
   Google Scholar
• U.S. Food and Drug Administration (FDA). (2007). Department of Health and Human Services, Pharmaceutical Quality for the 21st Century A Risk-Based Approach Progress Report, May 2007. http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm128080.html
   Google Scholar
• U.S. Food and Drug Administration (FDA). (2011). Department of Health and Human Services, Guidance for industry; Process validation: General Principles and Practices, January.
   Google Scholar